Does Every Necrotizing Granulomatous Inflammation Identified by NSCLC Resection Material Require Treatment?

Yakar F., Yakar A., Buyukpinarbasili N., Erelel M.

MEDICAL SCIENCE MONITOR, cilt.22, ss.1218-1222, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22
  • Basım Tarihi: 2016
  • Doi Numarası: 10.12659/msm.897638
  • Dergi Adı: MEDICAL SCIENCE MONITOR
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1218-1222
  • Anahtar Kelimeler: Antitubercular Agents, Carcinoma, Non-Small-Cell Lung, Tuberculosis, Pulmonary, RENAL-CELL CARCINOMA, LUNG-CANCER, PULMONARY TUBERCULOSIS, SARCOID REACTIONS, RISK, NEOPLASMS
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background: Lung cancer and tuberculosis (TB) are two major public health problems. They can coexist or appear sequentially. In patients with TB, lung cancer risk is increased. However, vice versa is not crystal clear. In this study, we aimed to determine the development of TB in patients with resectabled non-small cell lung cancer (NSCLC) in a 2-year postoperative follow-up period.